Dabrafenib and Trametinib Combination as a Neoadjuvant Strategy in BRAF-positive Anaplastic Thyroid Cancer
Clinical trial NCT04739566 · WITHDRAWN
Trial details
- NCT number
- NCT04739566
- Sponsor
- Saint Petersburg State University, Russia
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-22
- Primary completion
- 2023-12-22
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.